Therma Bright: A New Approach to Skin Care

Therma Bright is a progressive medical device technology company. Currently, they're focusing on providing consumers with quality medical devices that …

Therma Bright cold sore

A medical device company with bright ideas

Therma Bright is a progressive medical device technology company. Currently, they're focusing on providing consumers with quality medical devices that address their dermatological needs.

Therma Bright has spent a significant investment in intellectual property and research and development. This is for its InterceptCS™- cold sore device, the Therozap™ insect device, and will soon invest in a novel pain relief device.  Its current product lines address cold sore treatment and prevention. It also addresses the treatment of pain, itch and inflammation related to mosquito, bee, spider, mite, and jellyfish bites or stings.

Further, the Company is in the research and development stage to develop a novel device for relief of pain. This will target pain associated with back, knee or other joint pain. Moreover, they're focused on building recurring revenue streams from its products and to incorporate intelligent technology such as AI or IoT.

Additionally, the Company holds patents pending and trademarks. These are for Therozap™ and the trademark InterceptCS™ along with regulatory approvals for its thermal therapy technology.

For more information on Therma Bright Inc. (TSX.V: THRM) please fill out the form below.

You might also like

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs
Life Sciences
August 28, 2026

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs

Next-generation weight-management drugs face a simple challenge: effectiveness must be matched by tolerability.

This is some text inside of a div block.
Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?
Finance
August 27, 2026

Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?

This is some text inside of a div block.
Brompton Funds
ETFs
August 27, 2026

Brompton Funds: Enhanced Multi-Asset Income ETF - BMAX

BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

This is some text inside of a div block.
Subscribe and receive the investor Info